Colleen E Casey
4PUBLICATIONS
57CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Aug 14, 2025
A humanized anaplastic lymphoma kinase (ALK)-directed antibody-drug conjugate with pyrrolobenzodiazepine payload demonstrates efficacy in ALK-expressing cancers.Alberto D Guerra, Smita Matkar, Christina Acholla
|Feb 05, 2025
Kinome Reprogramming of G2/M Kinases and Repression of MYCN Contribute to Superior Efficacy of Lorlatinib in ALK-Driven Neuroblastoma.Smita Matkar, Michael P East, Timothy J Stuhlmiller
|Jul 31, 2024
Identification and Characterization of Chemotherapy-Resistant High-Risk Neuroblastoma Persister Cells.Liron D Grossmann, Chia-Hui Chen, Yasin Uzun
|May 05, 2023
Circulating tumor DNA reveals mechanisms of lorlatinib resistance in patients with relapsed/refractory ALK-driven neuroblastoma.Esther R Berko, Gabriela M Witek, Smita Matkar
Pageof 1
Frequent Collaborators
4 joint publications
Mark Gerelus
4 joint publications
John M Maris
4 joint publications
Yaël P Mossé
3 joint publications
Joshua R Kalna
2 joint publications
Gabriela Witek
2 joint publications
Alvin Farrel
2 joint publications
Khushbu Patel
2 joint publications
Kateryna Krytska
2 joint publications
Adam J Wolpaw
2 joint publications
David Groff
